Multi-center, Randomized, Double-blinded Assessment of TERIFLUNOMIDE (Aubagio®) in Extending the Time to the First Attack in Radiologically Isolated Syndrome: Baseline Characteristics of the TERIS Study. (P5-4.011)
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
10.1212/wnl.98.18_supplement.1116